Study Condition(s): Episodic Cluster Headache
A Study of LY2951742 in Participants With Episodic Cluster Headache
Study Alias: CGAL
The main purpose of this study is to evaluate the efficacy and safety of the study drug known as LY2951742 in participants with episodic cluster headaches.
The results of this study are not yet available.
Here you can find out a bit more about the requirements for volunteers who took part in this study
Participant must present with a history of episodic cluster headache (investigator to provide more details)
Participant must be able to distinguish cluster headache attacks from other headaches
Participant must not be taking indomethacin
Female participant must not be pregnant or nursing